TSO3 - News Feed http://www.tso3.com/ TSO3 ANNOUNCES FINANCIAL RESULTS FOR Q1 2012 Quebec City, May 9, 2012 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, posted total revenues of $780,291 for the first quarter of 2012 ending March 31, for the sale of 3M™ Optreoz™ 125-Z Sterilizers, consumable supplies, accessories, service and license revenues. 2012-05-09 00:00:00 http://www.tso3.com/en/news_events/article/38 TSO3: Q1 2012 FINANCIAL RESULTS CONFERENCE CALL Quebec City, May 1, 2012 - TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce that it will report Financial Results for the First Quarter 2012 ended March 31, 2012 on Wednesday, May 9, 2012. TSO3 will host a Conference Call and a Webcast at 10:30 A.M. (ET) the same day. 2012-05-01 00:00:00 http://www.tso3.com/en/news_events/article/37 TSO3 COMPLETES A $8.97 MILLION BOUGHT DEAL PRIVATE PLACEMENT - Quebec City, April 24, 2012 – TSO3 Inc. (TSX: TOS) ("TSO3" or the "Corporation") is pleased to announce the closing of a private placement on a firm underwritten basis for the purchase of 6,900,000 units (including the underwriters' option) at CAD $1.30 per unit (the "Issue Price"), for total gross proceeds of CAD $8,970,000. 2012-04-24 00:00:00 http://www.tso3.com/en/news_events/article/35 TSO3 RESUBMITS DOCUMENTS TO PROCEED WITH US REGULATORY CLEARANCE Quebec City, April 20, 2012 – TSO3 Inc. (“TSO3”) (TSX: TOS), announced today that it is resubmitting documentation to the United States (U.S.) regulatory authorities for the STERIZONE® 125L+ Sterilizer (3M™ Optreoz™ 125-Z) and associated accessories. This filing is aimed at obtaining clearance for the new generation sterilizer for commercialization in the United States. 2012-04-20 00:00:00 http://www.tso3.com/en/news_events/article/34 TSO3 TO HOLD ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS ON APRIL 25, 2012 Quebec City, April 16, 2012 – TSO3 Inc. is pleased to announce it will hold its Annual and Special Meeting of Shareholders on Wednesday April 25, 2012. 2012-04-16 00:00:00 http://www.tso3.com/en/news_events/article/33 TSO3 ANNOUNCES FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL UNITS Quebec City, April 5, 2012 – TSO3 Inc. (TSX: TOS) ("TSO3" or the "Corporation"), today announced that in relation to the private placement of units on a bought deal basis (the “Offering”) announced earlier this week, the underwriters have exercised their option (the "Underwriters' Option") to purchase an additional 900,000 units at a price of CDN$1.30 per unit. 2012-04-05 00:00:00 http://www.tso3.com/en/news_events/article/32 TSO3 ANNOUNCES $7.8 MILLION BOUGHT PRIVATE PLACEMENT Quebec City, April 2, 2012 – TSO3 Inc. (TSX: TOS) ("TSO3" or the "Corporation"), is pleased to announce it has entered into an agreement with a syndicate of underwriters led by Desjardins Capital Markets and Canaccord Genuity Corporation and including Byron Capital Markets (collectively, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal private placement basis, 6,000,000 units (the "Units") in the capital of TSO3 at the price of $1.30 per Unit (the "Issue Price") for aggregate gross proceeds to TSO3 of $7,800,000 (the "Offering"). 2012-04-02 00:00:00 http://www.tso3.com/en/news_events/article/31 TSO3 DISCLOSES FOURTH QUARTER AND FULL YEAR 2011 FISCAL RESULTS Quebec City, March 14, 2012 – TSO3 Inc. (“TSO3”) today reported revenues for the fiscal year ended December 31, 2011 totalling $3,355,437 representing the sale of sterilizers, consumable supplies, accessories, service contracts, training, after-sales service and the recording of license revenues for its new sterilizer (3M™ Optreoz™ 125-Z). This compares to $1,140,789 million the previous year.   2012-03-14 06:35:00 http://www.tso3.com/en/news_events/article/29 TSO3 TO FILE ADDITIONAL DATA REQUESTED BY THE US REGULATORY AGENCY Quebec City, March 12, 2012 – TSO3 Inc. (“TSO3”) (TSX: TOS), today announced that it will provide  additional data to the US Regulatory Agency in support of obtaining  510(k) clearance for its new sterilizer in the US market. The Company had previously responded to questions from the Agency and some of the answers now require additional clarification.  The Company will resubmit with the required information as promptly as the new data is available. 2012-03-12 00:00:00 http://www.tso3.com/en/news_events/article/28 TSO3: ANNOUNCEMENT OF 2011 ANNUAL RESULTS RELEASE Quebec City, Quebec, Canada, February 20, 2012 – TSO3 Inc. (“TSO3”) (TSX: TOS), today announced that it will report the Company’s annual financial results ending December 31, 2011, on Wednesday, March 14, 2012. TSO3 will host a conference call at 10:30 A.M. (EST) the same day. 2012-02-20 00:00:00 http://www.tso3.com/en/news_events/article/26